Hagens Berman Sobol Shapiro Cases

Bayer Healthcare

Date Filed: November 17, 2008

Court: U.S. District Court

Location: New Jersey

Ticker Symbol: BAY

Hagens Berman Sobol Shapiro filed a proposed class action against Bayer Healthcare for potentially illegally marketing two unapproved drugs, Bayer Aspirin with Heart Advantage and Bayer Women's Low Dose Aspirin + Calcium.

Both of the drugs are currently sold over-the-counter and according to the Food and Drug Administration require an approved new drug application to be considered for legal marketing.

The drugs both contain aspirin with either phytosterols or calcium in addition to being labeled as pain relievers. Both drugs promote use of the pills to reduce the risks of heart disease while the women's low dose aspirin also claims to fight osteoporosis. Currently the two drugs are only FDA approved for pain treatment, according to reports.

Reports indicate these drugs require a health care professional's diagnosis and supervision, meaning these products can't be labeled for use by consumers and the FDA bans such drugs from over-the-counter sales altogether.

If you've ever purchased either of the drugs, we'd like to hear from you. You can join this investigation, e-mail info@hbsslaw.com or call (206) 623-7292.